Beranda › Glioblastoma › Illinois › Chicago
Uji klinis Glioblastoma di Chicago, IL
15 studi untuk Glioblastoma mencari peserta di lokasi sekitar Chicago (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
Menerima pesertaFase 1/2
- University of Chicago Comprehensive Cancer Center, Chicago
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
Menerima pesertaFase 3
- Northwestern University, Chicago
A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
Menerima pesertaFase 1
- Northwestern Univerity, Chicago
A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
Menerima pesertaFase 1/2
- Northwestern Memorial Hospital, Chicago
Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma
Menerima pesertaFase 1
- Northwestern University, Chicago
Targeted Pediatric High-Grade Glioma Therapy
Menerima pesertaStudi observasional
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
Menerima pesertaFase 1
- Northwestern University, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
Study of Olutasidenib and Temozolomide in HGG
Menerima pesertaFase 2
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Menerima pesertaFase 3
- University of Chicago, Chicago
A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma
Menerima pesertaFase 1
- Northwestern Medicine, Chicago
WP1066 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
Menerima pesertaFase 2
- Northwestern University, Chicago
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
Menerima pesertaFase awal 1Sukarelawan sehat diterima
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
Menerima pesertaFase 2
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Menerima pesertaFase 1/2
- Northwestern Memorial Hospital, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Chicago
Uji klinis Glioblastoma di kota lain
- New York City, NY30 studi
- Boston, MA28 studi
- Houston, TX25 studi
- Los Angeles, CA23 studi
- Durham, NC20 studi
- San Francisco, CA17 studi
- Washington, DC15 studi
- Rochester, MN15 studi
- Columbus, OH14 studi
- Miami, FL14 studi
- Jacksonville, FL13 studi
- Aurora, CO12 studi
Studi lain di Chicago
- Kanker Paru Non-Sel Kecil61 studi
- Kanker Payudara58 studi
- Kanker (semua jenis)51 studi
- Kanker Metastatik45 studi
- Kanker Prostat45 studi
- Obesitas41 studi
- Kanker Paru41 studi
- Kanker Ovarium36 studi
- Stroke34 studi
- Kanker Kolorektal33 studi
- Gagal Jantung31 studi
- Kelebihan Berat Badan28 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.